Aditya Birla Real Estate Ltd
NSE:ABREL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aditya Birla Real Estate Ltd
NSE:ABREL
|
IN |
|
Evoke Pharma Inc
NASDAQ:EVOK
|
US |
|
Australia and New Zealand Banking Group Ltd
ASX:ANZ
|
AU |
|
B
|
Bimobject AB
STO:BIM
|
SE |
|
Predictive Technology Group Inc
OTC:PRED
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABREL's stock price target?
Not Available
ABREL doesn't have any price targets made by Wall Street professionals.
What is Aditya Birla Real Estate Ltd's Revenue forecast?
Projected CAGR
-2%
For the last 13 years the
compound annual growth rate for
Aditya Birla Real Estate Ltd's revenue is
0%.
The projected
CAGR
for the next 4 years is
-2%.
What is Aditya Birla Real Estate Ltd's Operating Income forecast?
Projected CAGR
30%
For the last 13 years the
compound annual growth rate for
Aditya Birla Real Estate Ltd's operating income is
1%.
The projected
CAGR
for the next 4 years is
30%.
What is Aditya Birla Real Estate Ltd's Net Income forecast?
Projected CAGR
100%
For the last 13 years the
compound annual growth rate for
Aditya Birla Real Estate Ltd's net income is
-11%.
The projected
CAGR
for the next 4 years is
100%.
